1H Magnetic Resonance Spectroscopy Assessment of the Effects of Rivastigmine on Patients with moderate Alzheimer Disease. VITAE [Internet]. 2025 Jul. 17 [cited 2025 Dec. 6];3(24). Available from: http://190.169.167.164/ojs-3.4.0-8/index.php/vitae/article/view/391